BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32323176)

  • 21. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis.
    Lyu Y; Wu L; Wang F; Shen X; Lin D
    Exp Biol Med (Maywood); 2018 Apr; 243(7):613-620. PubMed ID: 29534601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Aspergillus fumigatus infection in rats affects gastrointestinal homeostasis.
    Kulas J; Mirkov I; Tucovic D; Zolotarevski L; Glamoclija J; Veljovic K; Tolinacki M; Golic N; Kataranovski M
    Immunobiology; 2019 Jan; 224(1):116-123. PubMed ID: 30348457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The germ-organ theory of non-communicable diseases.
    Byndloss MX; Bäumler AJ
    Nat Rev Microbiol; 2018 Feb; 16(2):103-110. PubMed ID: 29307890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of gut microbiota in the pathogenesis of rheumatic diseases.
    Zhong D; Wu C; Zeng X; Wang Q
    Clin Rheumatol; 2018 Jan; 37(1):25-34. PubMed ID: 28914372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota.
    Peterson CT; Sharma V; Elmén L; Peterson SN
    Clin Exp Immunol; 2015 Mar; 179(3):363-77. PubMed ID: 25345825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota and Liver Injury (II): Chronic Liver Injury.
    Baker SS; Baker RD
    Adv Exp Med Biol; 2020; 1238():39-54. PubMed ID: 32323179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy.
    Kang Y; Cai Y
    J Hosp Infect; 2017 Aug; 96(4):342-348. PubMed ID: 28545829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease.
    Chen YY; Chen DQ; Chen L; Liu JR; Vaziri ND; Guo Y; Zhao YY
    J Transl Med; 2019 Jan; 17(1):5. PubMed ID: 30602367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of gut microbiota in liver disease.
    Albhaisi SAM; Bajaj JS; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G84-G98. PubMed ID: 31657225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota: From Microorganisms to Metabolic Organ Influencing Obesity.
    Stephens RW; Arhire L; Covasa M
    Obesity (Silver Spring); 2018 May; 26(5):801-809. PubMed ID: 29687647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbiota and organophosphates.
    Roman P; Cardona D; Sempere L; Carvajal F
    Neurotoxicology; 2019 Dec; 75():200-208. PubMed ID: 31560873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease.
    Yang T; Richards EM; Pepine CJ; Raizada MK
    Nat Rev Nephrol; 2018 Jul; 14(7):442-456. PubMed ID: 29760448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.